This is a list of all the questions and their associated study carrel identifiers. One can learn a lot of the "aboutness" of a text simply by reading the questions.
identifier | question |
---|---|
cord-029547-9ei1ram3 | A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Characteristics of ocular findings of patients with coronavirus disease 2019( COVID-19 Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
cord-252771-6kwfulqe | The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus Voluntary collective isolation as a best response to COVID-19 for indigenous populations? |
cord-268065-mxvbbkc4 | ; so how about COVID-19? |
cord-274459-781by93r | Why does Japan have so few cases of COVID-19? |
cord-268561-vq1uhj5i | A Prospective Cohort Study Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease Likelihood of survival of coronavirus disease Cutaneous manifestations in COVID-19: the experiences of Barcelona and Rome Cutaneous small- vessel vasculitis associated with novel 2019 coronavirus SARS- CoV-2 infection( COVID-19) Cutaneous manifestations in COVID-19: a first perspective Cutaneous manifestations of COVID-19: A review of the published literature Olfactory and gustatory dysfunctions as a clinical presentation of mild- to- moderate forms of the coronavirus disease Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease( COVID-19) Pneumonia: A Multicenter Study Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Diagnosis of the Coronavirus disease( COVID-19): rRT- PCR or CT? |
cord-280029-g1k3zlax | COVID-19: what is next for public health? |
cord-032928-m0awip9y | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
cord-032928-m0awip9y | Covid-19 pandemic and the skin- what should dermatologists know? |
cord-283310-5wam14aa | Can you catch the coronavirus twice? |
cord-288500-ko4eda9w | Does conflict between home and work explain the effect of multiple roles on mental health? |
cord-283152-wav0d0ws | The FDA- approved drug ivermectin inhibits the replication of SARS- CoV-2 in vitro Coronavirus disease( COVID-19): a primer for emergency physicians New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
cord-294136-e69ao8j0 | Since asymptomatic transmission is an established fact, how many individuals in the infected population are attributed to asymptomatic transmission? |
cord-279363-4almssg6 | What we know? |
cord-300608-eju7wnb9 | medRxiv Identifying medical diagnoses and treatable diseases by image- based deep learning Outbreak of novel coronavirus( COVID-19): What is the role of radiologists? |
cord-300899-yi2mx91a | A boon or inutile SARS- CoV-2 pandemic in India: What might we expect? |
cord-296692-t5p09le8 | What next? |
cord-309302-n6cd2fc3 | Chloroquine is a potent inhibitor of SARS coronavirus infection and spread Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus( 2019-nCoV) in vitro Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial Convalescent plasma: new evidence for an old therapeutic tool? |
cord-294831-pem059zk | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
cord-294831-pem059zk | What caused lymphopenia in SARS and how reliable is the lymphokine status in glucocorticoid- treated patients? |
cord-280970-gy0kfhy6 | COVID-19: too little, too late? |
cord-280970-gy0kfhy6 | What to do next to control the 2019-nCoV epidemic? |
cord-254446-yxqbe1dj | : Facts and myths Impact of corticosteroid therapy on outcomes of persons with SARS- CoV-2, SARS- CoV, or MERS- CoV infection: a systematic review and meta- analysis COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? |
cord-254446-yxqbe1dj | Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS- CoV-2: an observational cohort study Viral dynamics of SARS- CoV-2 across a spectrum of disease severity in COVID-19 Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes Comparisons of viral shedding time of SARS- CoV-2 of different samples in ICU and non- ICU patients Lack of dyspnea in patients with Covid-19: another neurological conundrum? |
cord-254446-yxqbe1dj | The facts during the third epidemic Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long- term immunosuppression Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
cord-320632-369kax2m | Close to a Cure? – |
cord-314311-xbpb9nfi | What to do next to control the 2019-nCoV epidemic? |
cord-262104-oig3qrr7 | A Sneeze England and Wales see 20 000 excess deaths in care homes Wearing Face Masks in the Community During the COVID-19 Pandemic: Altruism and Solidarity Comparative tropism, replication kinetics, and cell damage profiling of SARS- CoV-2 and SARS- CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study Impact assessment of non- pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study 2020) Pandemics and the great evolutionary mismatch Rapid implementation of mobile technology for real- time epidemiology of COVID-19 Assessment of Deaths From COVID-19 and From Seasonal Influenza Coast- to- coast spread of SARS- CoV-2 during the early epidemic in the United States Asymptomatic Transmission, the Achilles'Heel of Current Strategies to Control Covid-19 Face Masks for the Public During the covid-19 Crisis Spread of SARS- CoV-2 in the Icelandic Population Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards Temporal dynamics in viral shedding and transmissibility of COVID-19 Estimates of global seasonal influenza- associated respiratory mortality: a modelling study Where are the ECDC and the EU- wide responses in the COVID-19 pandemic? |
cord-262104-oig3qrr7 | The Economist Presymptomatic SARS- CoV-2 Infections and Transmission in a Skilled Nursing Facility Airborne or Droplet Precautions for Health Workers Treating COVID-19? Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study Investigation of a COVID-19 outbreak in Germany resulting from a single travel- associated primary case: a case series |
cord-262104-oig3qrr7 | a modelling impact assessment Is the Coronavirus Airborne? |
cord-291687-kwu0otpi | The coronavirus is infecting and killing black Americans at an alarmingly high rate At the heart of the matter: unmasking and addressing COVID-19's toll on diverse populations Is racism a fundamental cause of inequalities in health? |
cord-291687-kwu0otpi | [ Registry[ Full COVID-19 Registry Dashboard Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-293167-3bd3adip | Associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
cord-293167-3bd3adip | Guillain- Barré syndrome following COVID-19: new infection, old complication? |
cord-351567-ifoe8x28 | Did pangolins spread the China coronavirus to people? |
cord-281281-knelqmzx | A fight for supremacy Type 1 interferons and the virus- host relationship: A lesson in détente Viruses and Interferons Recent insights into emerging coronaviruses Clinical characteristics of coronavirus disease 2019 in China Coronavirus infections and immune responses Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis Complement as a target in COVID-19? |
cord-281281-knelqmzx | Should we stimulate or suppress immune responses in COVID-19? |
cord-298899-lkrmg5qr | , it seems that Fuyang patients are not infectious What is Kawasaki disease and its possible link with COVID-19 in children? |
cord-298899-lkrmg5qr | Novel coronavirus pneumonia prevention and control program Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
cord-269909-1cso5cl4 | A case report of neonatal COVID-19 infection in China Perinatal transmission of COVID-19 associated SARS- CoV-2: should we worry? |
cord-269909-1cso5cl4 | Can SARS- CoV-2 infection be acquired in utero? |
cord-269909-1cso5cl4 | Why is COVID-19 so mild in children? |
cord-332268-x30svp5y | Is lithium a potential treatment for the novel Wuhan( 2019-nCoV) coronavirus? |
cord-301771-43fl2gwp | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
cord-301771-43fl2gwp | The next big threat to global health? |
cord-312730-4ejjmab4 | When will it be over?": an introduction to viral reproduction numbers, R 0 and R e. |
cord-304418-k9owyolj | -A systematic review of the literature, case series, and recommendations for clinical assessment and management Epidemiologie und therapie in Deutschland, Österreich und der Schweiz Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease COVID-19 and anosmia: A review based on up- to- date knowledge Self- reported olfactory and taste disorders in SARS- CoV-2 patients: a cross- sectional study Neurologic features in severe SARS- COV-2 infection Neurological manifestations and complications of COVID-19: A literature review A first Case of Meningitis/ Encephalitis associated with SARS- Coronavirus-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
cord-304418-k9owyolj | What Is a Pandemic? |
cord-355528-y4a1g6km | Accessed on The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
cord-315058-t7bq4yqw | COVID-19 control in low- income settings and displaced populations: what can realistically be done? |
cord-283440-8du0s33p | : should we worry? |
cord-283440-8du0s33p | How useful is the lung ultrasound in cystic fibrosis? |
cord-283440-8du0s33p | Why is COVID-19 so mild in children? |
cord-338979-ew046wcr | The art of medicine:"an inexpressible dread": psychoses of influenza at fin- de- siècle Outcome of delirium in critically ill patients: systematic review and meta- analysis Psychological impact on SARS sur- vivors: critical review of the English language literature Fear and stigma: the epidemic within the SARS outbreak Timely mental health care for the 2019 novel corona virus outbreak is urgently needed Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? |
cord-338979-ew046wcr | The neuroinvasive potential of SARS- CoV2 may play a role in the respiratory failure of COVID-19 patients Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
cord-305856-xt3zxajf | A cluster of cases of severe acute respiratory syndrome in Hong Kong Identification of severe acute respiratory syndrome in Canada Coronavirus in the United States Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records How can airborne transmission of COVID-19 indoors be minimised? |
cord-305856-xt3zxajf | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
cord-337572-kx5hihnr | WHAT ARE CORONAVIRUSES AND WHERE DO THEY COME FROM? |
cord-337572-kx5hihnr | an overview of their replication and pathogenesis Structural insights into coronavirus entry ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia Rates of evolutionary change in viruses: patterns and determinants RNA recombination in animal and plant viruses Cultivation of the virus of infectious bronchitis Animal coronaviruses: what can they teach us about the severe acute respiratory syndrome? |
cord-322087-gj5mfzxz | Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? |
cord-322087-gj5mfzxz | recommendations of the Advisory Committee on Immunization Practices- United States, 2019- 20 influenza season Are We Ready for Coronavirus Disease 2019 Arriving at Schools? |
cord-309970-jkmjiika | Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, People's Republic of China Clinical features of patients infected with 2019 novel coronavirus in Wuhan Labs scramble to produce new coronavirus diagnostics COVID-19, SARS and MERS: are they closely related? |
cord-309970-jkmjiika | From SARS to COVID-19: What lessons have we learned? |
cord-337302-fpz2jfuj | ; how do we manage cancer optimally through a public health crisis? |
cord-337302-fpz2jfuj | Blood Advances Immune checkpoint inhibitors in SARS- CoV-2 infected cancer patients: the spark that ignites the fire? |
cord-337302-fpz2jfuj | Which cancer type has the highest risk of COVID-19 infection? |
cord-268939-ws74xprt | How do extracellular pathogens cross the blood- brain barrier? |
cord-268939-ws74xprt | Is this just a lot of hot air? |
cord-268939-ws74xprt | May we deliver neuro- oncology in difficult times( e.g. COVID-19)? |
cord-268939-ws74xprt | The perioperative immune response Does major surgery induce immune suppression and increase the risk of postoperative infection? |
cord-268939-ws74xprt | as Compared with SARS- CoV-1 Letter: Rongeurs, Neurosurgeons, and COVID-19: How Do We Protect Health Care Personnel During Neurosurgical Operations in the Midst of Aerosol- Generation From High- Speed Drills? |
cord-277260-7se220oz | COVID-19 and surgery Timing of breast cancer surgery- how much does it matter? |
cord-277260-7se220oz | Could intravenous immunoglobulin collected from recovered coronavirus patients protect against COVID-19 and strengthen the immune system of new patients? |
cord-277260-7se220oz | TMPRSS2 CD24 and Fc fusion protein protects SIVmac239-infected Chinese rhesus macaque against progression to AIDS Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non- randomized clinical trial Should chloroquine and hydroxychloroquine be used to treat COVID-19? |
cord-277260-7se220oz | a case series Is there a role for tissue plasminogen activator( tPA) as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome( ARDS)? |
cord-277260-7se220oz | an opportunity for combination with cytokines? |
cord-299333-qu0bmov5 | Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
cord-299333-qu0bmov5 | Can COVID-19 present unusual GI symptoms? |
cord-299333-qu0bmov5 | Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system? |
cord-299333-qu0bmov5 | What will be the economic impact of COVID-19 in the US? |
cord-293127-c27qh5y7 | , it is necessary to think forwards towards a resumption of services and a number of questions need to be answered around the management of ART: Should we cancel all ART cycles at this moment? |
cord-293127-c27qh5y7 | A novel coronavirus associated with severe acute respiratory syndrome Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus- Infected Pneumonia Novel corona virus disease( COVID-19) in pregnancy: What clinical recommendations to follow? |
cord-293127-c27qh5y7 | Should we keep only embryo transfers for couple whose success of treatment can be impaired or those who desire transfer the embryos? |
cord-293127-c27qh5y7 | Should we keep the treatments and postpone all embryo transfers? |
cord-293127-c27qh5y7 | à Saúde A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person- to- person transmission: a study of a family cluster Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China Pregnant women with new coronavirus infection: a clinical characteristics and placental pathological analysis of three cases Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus( COVID-19) infection Identification of a novel coronavirus in patients with severe acute respiratory syndrome Perinatal Transmission of COVID-19 Associated SARS- CoV-2: Should We Worry? |
cord-316647-jj8anf5g | Does pulse pressure variation predict fluid responsiveness in critically ill patients? |
cord-316647-jj8anf5g | The convalescent sera option for containing COVID-19 Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
cord-316647-jj8anf5g | Use of convalescent plasma therapy in SARS patients in Hong Kong Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A( H1N1) 2009 virus infection Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience Treatment of 5 critically ill patients with COVID-19 with convalescent plasma Effectiveness of convalescent plasma therapy in severe COVID-19 patients Convalescent plasma: new evidence for an old therapeutic tool? |
cord-316647-jj8anf5g | a study on coronary artery bypass graft surgery patients Monitoring sound and light continuously in an intensive care unit patient room: a pilot study The efficacy of earplugs as a sleep hygiene strategy for reducing delirium in the ICU: a systematic review and meta- analysis Effect of dexmedetomidine added to standard care on ventilatorfree time in patients with agitated delirium: a randomized clinical trial Melatonin decreases delirium in elderly patients: a randomized, placebo- controlled trial Preventive effects of ramelteon on delirium: a randomized placebo- controlled trial Melatonin, ramelteon, suvorexant, and dexmedetomidine to promote sleep and prevent delirium in critically ill patients: a narrative review with practical applications Interpreting and implementing the 2018 pain, agitation/ sedation, delirium, immobility, and sleep disruption clinical practice guideline Sedation with sufentanil in patients receiving pressure support ventilation has no effects on respiration: a pilot study Could remifentanil reduce duration of mechanical ventilation in comparison with other opioids for mechanically ventilated patients? |
cord-256508-ce59ovan | Are reinfections less severe than the first? |
cord-256508-ce59ovan | How does COVID-19 kill? |
cord-256508-ce59ovan | This case lead to several open questions: How frequent is reinfection? |
cord-256508-ce59ovan | Tracking down RNA synthesis Viral load dynamics and disease severity in patients infected with SARS- CoV-2 in Zhejiang province, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome A Novel Coronavirus from Patients with Pneumonia in China Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19 Treatment of hepatitis C virus infection with direct- acting antiviral agents: 100% cure? |
cord-256508-ce59ovan | Where does the virus replicate? |
cord-256508-ce59ovan | Will vaccine protect against reinfections? |
cord-343715-y594iewi | COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
cord-343715-y594iewi | CT and MRI features Guillain- Barré syndrome associated with SARS- CoV-2 Guillain- Barré syndrome associated with SARS- CoV-2 infection: causality or coincidence? |
cord-343715-y594iewi | Can the coronavirus disease 2019( COVID-19) affect the eyes? |
cord-343715-y594iewi | The Heart in COVID19: primary target or secondary bystander? |
cord-300763-3ateeei3 | What Is COVID-19? |
cord-300763-3ateeei3 | What happened? |
cord-300763-3ateeei3 | medRxiv Responding to community spread of COVID-19 interim guidance Coronavirus: when will a COVID-19 vaccine be ready? |
cord-300763-3ateeei3 | what next? |
cord-279180-xad53zht | How does the Aarogya Setu app work? |
cord-279180-xad53zht | How is COVID-19 impacting the environment around us? |
cord-279180-xad53zht | Official site of Immuni app Increase of online usage( 2020) Are gamers breaking the internet during quarantine? |
cord-279180-xad53zht | What is the probability of the ineffectiveness of a medication for a specific person or group? |
cord-279180-xad53zht | What is the risk of extreme COVID-19 symptoms or complications requiring hospitalization or intensive care of a specific patient or group? |
cord-279180-xad53zht | What is the risk of having COVID-19 for a specific person or group? |
cord-271504-t3y1w9ef | , its homologue ACE2 and neprilysin in angiotensin peptide metabolism COVID-19 and angiotensinconverting enzyme inhibitors and angiotensin receptor Blockers Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-271504-t3y1w9ef | : lessons from severe acute respiratory syndrome and Middle East respiratory syndrome Radiology of severe acute respiratory syndrome( SARS): the emerging pathologic- radiologic correlates of an emerging disease Middle East respiratory syndrome coronavirus: what does a radiologist need to know? |
cord-271504-t3y1w9ef | A human monoclonal antibody blocking SARS- CoV-2 infection Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes IgM in microbial infections: taken for granted? |
cord-271504-t3y1w9ef | The SARS- coronavirus papain- like protease: structure, function and inhibition by designed antiviral compounds Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate- like Aza- peptide Epoxide Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry Protease inhibitors targeting coronavirus and filovirus entry Efficacy of camostat mesilate compared with famotidine for treatment of functional dyspepsia: is camostat mesilate effective? |
cord-271504-t3y1w9ef | The broad- spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen Signatures of nucleotide analog incorporation by an RNA- dependent rna polymerase revealed using high- throughput magnetic tweezers Ribavirin in the treatment of SARS: a new trick for an old drug? |
cord-271504-t3y1w9ef | What happens to people's lungs when they get coronavirus? |
cord-311044-kjx0z1hc | Are the facilities satisfactory to operate safely? |
cord-311044-kjx0z1hc | British society of Thoracic Imaging statement Thailand joins the WHO"Solidarity Trial": global testing of effective treatments of COVID-19 across 8 countries-an aggressive effort to save lives from the pandemic( press release) Could chloroquine/hydroxychloroquine be harmful in Coronavirus Disease 2019( COVID-19) treatment? |
cord-311044-kjx0z1hc | COVID-19 status: does the patient present a concomitant viral infection in addition to the surgical disease? |
cord-311044-kjx0z1hc | sufficient protective material( personal protective equipment[ PPE])? |
cord-311044-kjx0z1hc | there any alternative treatments other than surgery that would be safe for the patient? |
cord-340063-nmx91h0a | As normalcy returns, can China keep COVID-19 at bay? |
cord-340063-nmx91h0a | COVID-19 and Italy: what next? |
cord-340063-nmx91h0a | How will country- based mitigation measures influence the course of the COVID-19 epidemic? |
cord-340063-nmx91h0a | The COVID-19 pandemic in the USA: what might we expect? |
cord-340063-nmx91h0a | The lockdowns worked- but what comes next? |
cord-349313-2gupfqnl | Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019( COVID-19)? |
cord-349313-2gupfqnl | Public Health Coronavirus mapping in scientific publications: When science advances rapidly and collectively, is access to this Knowledge open to society? |
cord-349313-2gupfqnl | SARS- CoV-2 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-349313-2gupfqnl | Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019( COVID-19) COVID-19 and Italy: What next? |
cord-349313-2gupfqnl | What lessons have we learned? |
cord-354824-7fdcu2f0 | Evaluation of the efficacy and safety of sarilumab in hospitalized patients with COVID-19 Overview of the IL-1 family in innate inflammation and acquired immunity Personalised immunotherapy for SARS- CoV-2( COVID-19) associated with organ dysfunction Clinical course and outcomes of critically ill patients with SARS- CoV-2 pneumonia in Wuhan, China: a single- centered, retrospective, observational study Clinical characteristics of coronavirus disease 2019 in China Clinical characteristics of 140 patients infected with SARS- CoV-2 in Wuhan Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-354824-7fdcu2f0 | Investigating mechanism of Qingfei Dayuan granules for treatment of COVID-19 based on network pharmacology and molecular docking Study on screening potential traditional Chinese medicines against 2019-nCoV based on Mpro and PLP Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and metaanalysis Traditional Chinese herbal medicine as a source of molecules with antiviral activity Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
cord-354824-7fdcu2f0 | The host immune response in respiratory virus infection: balancing virus clearance and immunopathology Groups at higher risk for severe illness Coronavirus and COVID-19: who is at higher risk? |
cord-354824-7fdcu2f0 | Why tocilizumab could be an effective treatment for severe COVID-19? |
cord-354824-7fdcu2f0 | identifies potential anti- coronavirus drugs Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus Meta- analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
cord-303517-8971aq02 | -The Editors Speak Out Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19? |
cord-303517-8971aq02 | A Trial of Lopinavir- Ritonavir in Adults Hospitalized with Severe Covid-19 Centro Nacional de Información de Ciencias Médicas Incidence and Severity of COVID-19 in HIV- Positive Persons Receiving Antiretroviral Therapy Could HIV infection alter the clinical course of SARS- CoV-2 infection? |
cord-303517-8971aq02 | Mult Scler Houndmills Basingstoke Engl COVIDa MS patient treated with ocrelizumab: does immunosuppression have a protective role? |
cord-303517-8971aq02 | Should cyclosporine be useful in renal transplant recipients affected by SARS- CoV-2? |
cord-303517-8971aq02 | When less is better Maintaining HIV care during the COVID-19 pandemic Biomarkers of immunosuppression Immunosuppression for the non- transplant physician: what should you know? |
cord-303517-8971aq02 | a narrative review Attenuated early inflammatory response in solid organ recipients with COVID-19 Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? |
cord-294800-akr4f5p8 | : what's next? |
cord-294800-akr4f5p8 | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
cord-294800-akr4f5p8 | Teicoplanin: an alternative drug for the treatment of COVID-19? |
cord-294800-akr4f5p8 | The FDA- approved drug ivermectin inhibits the replication of SARS- CoV-2 in vitro Nuclear trafficking of proteins from RNA viruses: potential target for antivirals? |
cord-294800-akr4f5p8 | The mercurial nature of neutrophils: still an enigma in ARDS? |
cord-294800-akr4f5p8 | a retrospective cohort study Characterization of SARS- CoV- specific memory T cells from recovered individuals 4 years after infection Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-294800-akr4f5p8 | emergence and implications for emergency care Enteric involvement of coronaviruses: is faecal- oral transmission of SARS- CoV-2 possible? |
cord-346389-gbmnoo84 | COVID-19 and diabetes: can DPP4 inhibition play a role? |
cord-346389-gbmnoo84 | COVID-19) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Pulmonary embolism or pulmonary thrombosis in COVID-19? |
cord-346389-gbmnoo84 | Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS- CoV Remdesivir in adults with severe COVID-19: a randomised, double- blind, placebo- controlled, multicentre trial Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19 Available online at Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus Survival after mesenchymal stromal cell therapy in steroidrefractory acute graft- versus- host disease: systematic review and metaanalysis Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia Extraordinary GUrich single- strand RNA identified from SARS coronavirus contributes an excessive innate immune response Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment Effective treatment of severe COVID-19 patients with tocilizumab Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab Tocilizumab, an anti- IL6 receptor antibody, to treat Covid-19-related respiratory failure: a case report Rapid and severe Covid-19 pneumonia with severe acute chest syndrome in a sickle cell patient successfully treated with tocilizumab Dissection of the effects of jak and btk inhibitors on the functionality of healthy and malignant lymphocytes COVID-19: combining antiviral and anti- inflammatory treatments Baricitinib for COVID-19: a suitable treatment? |
cord-346389-gbmnoo84 | Do men have a higher case fatality rate of severe acute respiratory syndrome than women do? |
cord-346389-gbmnoo84 | Is the recommendation to use high- dose heparin for thromboprophylaxis justified? |
cord-346389-gbmnoo84 | Where are we? |
cord-346389-gbmnoo84 | the battle continues Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-029332-yn603pvb | COVID-19 pneumonia: a random association? |
cord-029332-yn603pvb | COVID-19 pneumonia: a random association? |
cord-029332-yn603pvb | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Direct oral anticoagulants for the treatment of left ventricular thrombus- a new indication? |
cord-029332-yn603pvb | Intraventricular thrombus and severe mitral regurgitation in the acute phase of Takotsubo cardiomyopathy: two case reports Endothelial cell infection and endotheliitis in COVID-19 ISTH interim guidance on recognition and management of coagulopathy in COVID-19 Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia Acute pulmonary embolism and COVID-19 pneumonia: a random association? |
cord-029332-yn603pvb | The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS- CoV-2 Soluble angiotensin- converting enzyme 2: a potential approach for coronavirus infection therapy? |
cord-029332-yn603pvb | what next? |
cord-029332-yn603pvb | what next? |
cord-029332-yn603pvb | where are the heart attacks and strokes? |
cord-354658-v451z3jq | : what to expect for COVID-19? |
cord-354658-v451z3jq | How to approach therapeutic futility for termination? |
cord-354658-v451z3jq | Left ventricular distension in veno- arterial extracorporeal membrane oxygenation: From mechanics to therapies Mechanical unloading in heart failure Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support How small is enough for the left heart decompression cannula during extracorporeal membrane oxygenation? |
cord-354658-v451z3jq | Should ECMO be considered for COVID-19 patients? |
cord-354658-v451z3jq | Should ECMO during CPR( E- CPR) be considered for COVID-19 patients? |
cord-354658-v451z3jq | The Wuhan coronavirus Real- time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, people's republic of China, in february Characteristics of and important lessons from the Coronavirus Disease 2019( COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention Structural and functional basis of SARS- CoV-2 entry by using human ACE2 A pneumonia outbreak associated with a new coronavirus of probable bat origin Bats: Important reservoir hosts of emerging viruses Probable pangolin origin of 2019-nCoV associated with outbreak of COVID-19 The emergence of a novel coronavirus( SARS- CoV-2), their biology and therapeutic options Structural basis for the recognition of SARS- CoV-2 by full- length human ACE2 Cryo- EM structure of the 2019-nCoV spike in the prefusion conformation Structure of the SARS- CoV-2 spike receptorbinding domain bound to the ACE2 receptor Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study COVID-19): A perspective from China COVID-19 Retrospective Study of Chest CTs from China: What is the Relationship to Duration of Infection? |
cord-354658-v451z3jq | What protective measures for the team should be used? |
cord-350015-mg5wiihj | : why are children overwhelmingly spared? |
cord-350015-mg5wiihj | A comparative analysis of control measures on- board ship against COVID-19 and similar novel viral respiratory disease outbreak: Quarantine ship or disembark suspects? |
cord-350015-mg5wiihj | But does it matter? |
cord-350015-mg5wiihj | COVID-19 Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? Antibody responses to SARS- CoV-2 in patients of novel coronavirus disease 2019 Epidemiology and cause of severe acute respiratory syndrome( SARS) in Guangdong, People's Republic of China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: |
cord-350015-mg5wiihj | The Pathway to a Universal Influenza Vaccine Age and immunity: What is"immunosenescence Can an effective SARS- CoV-2 vaccine be developed for the older population? |
cord-350015-mg5wiihj | The ancient and the new": is there an interaction between cytomegalovirus and SARS- CoV-2 infection? |
cord-259229-e8m8m4ut | A potential approach for coronavirus infection therapy? |
cord-259229-e8m8m4ut | Admitted to ICUs of the Lombardy Region Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? |
cord-259229-e8m8m4ut | Compared to the Single X- Chromosome in Males? |
cord-259229-e8m8m4ut | Deleterious? |
cord-259229-e8m8m4ut | Direct regulation of interleukin-6 expression by Notch signaling in macrophages COVID-19 in the heart and the lungs: Could we"Notch"the inflammatory storm? |
cord-259229-e8m8m4ut | Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia Urinary angiotensin- converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker Renin- Angiotensin- Aldosterone System Blockers and the Risk of Covid-19 Inhibitors of the Renin- Angiotensin- Aldosterone System and Covid-19 Renin- Angiotensin- Aldosterone System Inhibitors and Risk of Covid-19 SARS- coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS COVID-19 Illness and Heart Failure: A Missing Link? |
cord-259229-e8m8m4ut | The COVID-19 pandemic in the USA: What might we expect? |
cord-259229-e8m8m4ut | The cardiac renin- angiotensin system: Conceptual, or a regulator of cardiac function? |
cord-259229-e8m8m4ut | The role of the Notch pathway The Notch pathway: A novel target for myocardial remodelling therapy? |
cord-327063-ea7a1xfl | Avian influenza and sialic acid receptors: more than meets the eye? |
cord-327063-ea7a1xfl | Based on SARS- CoV Immunological Studies Is COVID-19 receiving ADE from other coronaviruses? |
cord-327063-ea7a1xfl | COVID-19: what is next for public health? |
cord-327063-ea7a1xfl | Companion Animal Pets Is COVID-19 the first pandemic that evolves into a panzootic? |
cord-327063-ea7a1xfl | First respiratory transmitted food borne outbreak? |
cord-327063-ea7a1xfl | The Indian journal of animal sciences MERS- CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? |
cord-327063-ea7a1xfl | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
cord-327063-ea7a1xfl | What can animal coronaviruses tell us about emerging human coronaviruses? |
cord-284573-w0sk622m | ( COVID-19 Estimating Clinical Severity of COVID-19 from the Transmission Dynamics in Wuhan, China Is Barbarism with a Human Face Our Fate? |
cord-284573-w0sk622m | How can it be that hospitals ran out of N95 masks in week one? |
cord-284573-w0sk622m | How did we end up in a space of thinking, acting, and feeling that has normalized extremes and is based on the assumption that biological life is an absolute value separate from politics? |
cord-284573-w0sk622m | How did we end up in this strange space of thinking, acting, and feeling that has normalized extremes and that is based on the assumption that biological life is an absolute value separate from politics? |
cord-284573-w0sk622m | How was it possible for a virus to trigger such a massive response that continues to threaten society and the economy, with so little discussion about the costs and consequences of extreme measures? |
cord-284573-w0sk622m | Was it the only possible way of managing the crisis? |
cord-284573-w0sk622m | What could be more dangerous, more daring, more exciting than a walk on the wild side, an excursion to the other side of reason? |
cord-284573-w0sk622m | Where did all the billions spent on preparedness go? |
cord-284573-w0sk622m | Why has a crude version of China's approach become the dominant model? |
cord-284573-w0sk622m | Why is there widespread agreement that aggressive interventions to"flatten the curve"were necessary and justified? |
cord-286298-pn9nwl64 | : What is the role of radiologists? |
cord-286298-pn9nwl64 | Are aerosol, saliva, feces, urine, and foodborne the only routes of transmission? |
cord-286298-pn9nwl64 | Can Chinese medicine be used for prevention of corona virus disease 2019( COVID-19)? |
cord-286298-pn9nwl64 | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
cord-286298-pn9nwl64 | These unresolved questions include: What is the origin of SARS- CoV-2? |
cord-286298-pn9nwl64 | What are the other unknown routes of transmission? |
cord-286298-pn9nwl64 | What is the intermediate host that transmitted the virus from bats? |
cord-286298-pn9nwl64 | Why does the virus cause severe disease and mortality in the elderly or those with co- morbidities, while it is milder in children? |
cord-286298-pn9nwl64 | interferon signals in lung stromal cells protect from influenza virus infection Rescue fecal microbiota transplantation for antibiotic- associated diarrhea in critically ill patients Long- Term safety and efficacy of fecal microbiota transplant in active ulcerative colitis Microbiota and its role on viral evasion: Is it with us or against us? |
cord-033204-v17d98c9 | Amid high uncertainty, how to make collective sense of this crisis as a society? |
cord-033204-v17d98c9 | Here's the difference between asymptomatic and pre- symptomatic spread The secrete behind 8.5 times of mask production in 3 months: How did Taiwan do it? |
cord-033204-v17d98c9 | How do the public perceive the risks? |
cord-033204-v17d98c9 | Room for industrial upgrade? |
cord-033204-v17d98c9 | That is, how to cope with the uncertainty brought by or embedded in this crisis? |
cord-033204-v17d98c9 | There is obviously huge demand for facemasks during this crisis, but why is n't there corresponding supply? |
cord-033204-v17d98c9 | What are the lessons policymakers can learn from Taiwan's experience? |
cord-033204-v17d98c9 | What explains Taiwan's success? |
cord-033204-v17d98c9 | Why ca n't other countries mass- produce facemasks like Taiwan does? |
cord-033204-v17d98c9 | is privacy respected? |
cord-279255-v861kk0i | ( COVID-19) outbreak: could pigs be vectors for human infections? |
cord-279255-v861kk0i | 2019 novel coronavirus( 2019-nCoV): what advice can we give to travellers? |
cord-279255-v861kk0i | : what have we learned? |
cord-279255-v861kk0i | : what is the role of radiologists? |
cord-279255-v861kk0i | COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand- related issue? |
cord-279255-v861kk0i | Can SARS- CoV-2 infection be acquired in utero? |
cord-279255-v861kk0i | Can cats become infected with Covid-19? |
cord-279255-v861kk0i | Can companion animals become infected with Covid-19? Leading veterinary diagnostic company |
cord-279255-v861kk0i | Does SARS- CoV-2 has a longer incubation period than SARS and MERS? |
cord-279255-v861kk0i | However, the real question is, how are we planning to counter the next zoonotic CoV epidemic that is likely to occur within the next 5 to 10 years or perhaps sooner? |
cord-279255-v861kk0i | Influenza Other Respir Viruses Does hand hygiene reduce SARS- CoV-2 transmission? |
cord-279255-v861kk0i | More definitive evidence is needed Wuhan virus: Chinese animal markets reopened with almost no precautions China must close down"wet markets Will they ever learn? |
cord-279255-v861kk0i | Rational vaccine design in the time of COVID-19 Bacillus Calmette Guérin( BCG) vaccination use in the fight against COVID-19-what's old is new again? |
cord-279255-v861kk0i | Reply to"Does hand hygiene reduce SARS- CoV-2 transmission? |
cord-279255-v861kk0i | The establishment of reference sequence for SARS- CoV-2 and variation analysis Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
cord-279255-v861kk0i | The next big threat to global health? |
cord-279255-v861kk0i | What do we know about the SARS- CoV-2 coronavirus in the environment? |
cord-279255-v861kk0i | What is the potential impact of the Amazon wildfires on vector- borne and zoonotic emerging diseases? |
cord-279255-v861kk0i | and now the 2019-novel CoV: have we investigated enough about coronaviruses? |
cord-279255-v861kk0i | e12591 Infection and rapid transmission of SARS- CoV-2 in ferrets Current therapeutic applications and pharmacokinetic modulations of ivermectin Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment? |
cord-279255-v861kk0i | is faecal- oral transmission of SARS- CoV-2 possible? |
cord-279255-v861kk0i | proactive infection control measures against the emerging Wuhan coronavirus pneumonia in China Emerging viruses without borders: the Wuhan coronavirus China coronavirus: what do we know so far? |
cord-315598-qwh72inx | A Missing Link? |
cord-315598-qwh72inx | Ann Intensive Care Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta- analysis Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis- Associated Organ Dysfunction in Children Use of ECMO in ARDS: does the EOLIA trial really help? |
cord-315598-qwh72inx | COVID-19 pneumonia: ARDS or not? |
cord-315598-qwh72inx | COVID-19 pneumonia: different respiratory treatment for different phenotypes? |
cord-315598-qwh72inx | Can Lung US Help Critical Care Clinicians in the Early Diagnosis of Novel Coronavirus( COVID-19) Pneumonia? |
cord-315598-qwh72inx | Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients? |
cord-315598-qwh72inx | Cómo podemos medir la calidad de vida, en los pacientes con COVID-19 que egresan de la uci? |
cord-315598-qwh72inx | Documento de Rionegro Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019( COVID-19) COVID-19 pneumonia: different respiratory treatments for different phenotypes? |
cord-315598-qwh72inx | Does COVID19 Infect the Brain? |
cord-315598-qwh72inx | Does SARS- Cov-2 invade the brain? |
cord-315598-qwh72inx | Does central venous pressure predict fluid responsiveness? |
cord-315598-qwh72inx | Heart Lung Patient selfproning with high- flow nasal cannula improves oxygenation in COVID-19 pneumonia Expert Recommendations for Tracheal Intubation in Critically ill Patients with Noval Coronavirus Disease Intubation and Ventilation amid the COVID-19 Outbreak: Wuhan's Experience Sedation for critically ill patients with COVID-19: Which specificities? |
cord-315598-qwh72inx | How should health systems prepare for the evolving COVID-19 pandemic? |
cord-315598-qwh72inx | How will countrybased mitigation measures influence the course of the COVID-19 epidemic? |
cord-315598-qwh72inx | Incidence, clinical course, and outcome in 217 patients with acute respiratory distress syndrome Driving pressure and survival in the acute respiratory distress syndrome Driving pressure: a marker of severity, a safety limit, or a goal for mechanical ventilation? |
cord-315598-qwh72inx | Management of COVID-19 Respiratory Distress Stages or phenotypes? |
cord-315598-qwh72inx | Noninvasive ventilation in acute cardiogenic pulmonary edema Noninvasive Ventilation in Acute Heart Failure Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure Is there a role for noninvasive ventilation in acute respiratory distress syndrome? |
cord-315598-qwh72inx | Pautas COVID-19 HiSpaFlow) endGEMdTdScAFeA. Respiratory support therapy after extubation: Who and how? |
cord-315598-qwh72inx | Pdlr An international survey of training in adult intensive care medicine Do intensivist staffing patterns influence hospital mortality following ICU admission? |
cord-315598-qwh72inx | Por qué seguimos buscando métodos alternativos? |
cord-315598-qwh72inx | Radiography( Lond) Point- of- Care Lung Ultrasound Findings in Patients with COVID-19 Pneumonia Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic D- dimer in patients infected with COVID-19 and suspected pulmonary embolism Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Anticoagulation in COVID-19 Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections Procalcitonin to Distinguish Viral From Bacterial Pneumonia: A Systematic Review and Meta- analysis Procalcitonin in patients with severe coronavirus disease 2019( COVID-19): A meta- analysis Viral load of SARS- CoV-2 in clinical samples Discharge criteria for confirmed COVID-19 cases-When is it safe to discharge COVID-19 cases from the hospital or end home isolation? |
cord-315598-qwh72inx | The SARS, MERS and novel coronavirus( COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
cord-315598-qwh72inx | Underestimated Opportunistic Pathogens of the Central Nervous System? |
cord-315598-qwh72inx | What are the effects of multimodal campaigns to improve hand hygiene of healthcare workers? |
cord-315598-qwh72inx | Will This Hemodynamically Unstable Patient Respond to a Bolus of Intravenous Fluids? |
cord-315598-qwh72inx | a la bata manga larga con antifluido durante la atención del paciente con COVID-19? |
cord-315598-qwh72inx | beneficios en desenlaces clínicos de interés? |
cord-315598-qwh72inx | convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? |
cord-315598-qwh72inx | de COVID-19? |
cord-315598-qwh72inx | why, when and how? |
cord-283485-xit6najq | 36 84 What is the role of children in transmission? |
cord-283485-xit6najq | Acquired immunity is not very strong; hence, what is the consequence regarding herd immunity? ► |
cord-283485-xit6najq | After how many doses? ► How protective will it be against infection? |
cord-283485-xit6najq | After how many doses? ► How protective will it be against infection? |
cord-283485-xit6najq | And hence: how often will the vaccine have to be administered? |
cord-283485-xit6najq | COVID-19: What proportion are asymptomatic?: |
cord-283485-xit6najq | Continuous tides, with ups and downs? |
cord-283485-xit6najq | For how long will vaccine- acquired immunity last? |
cord-283485-xit6najq | Furthermore, benefits and costs are also related to the positionality from which they are analysed: benefits for whom and costs borne by whom? |
cord-283485-xit6najq | How expensive will the vaccine be? |
cord-283485-xit6najq | How long will it take to effectively vaccinate the critical population? |
cord-283485-xit6najq | How significant are asymptomatic carriers in transmission? |
cord-283485-xit6najq | How stable is the virus( mutation) and do the different clades seen worldwide have any effect on the transmission potential/ severity of the disease? |
cord-283485-xit6najq | If a vaccine is developed? |
cord-283485-xit6najq | Only once? |
cord-283485-xit6najq | Or will vaccine hesitancy reduce uptake? |
cord-283485-xit6najq | Or yearly? |
cord-283485-xit6najq | Quasi- absence of disease in children: why? |
cord-283485-xit6najq | Seasonal transmission in temperate climate? ► |
cord-283485-xit6najq | Some critical unknowns in SARS- CoV-2 transmission Which transmission patterns will occur and will human- to- human transmission continue permanently? |
cord-283485-xit6najq | The role of antibody testing for SARS- CoV-2: is there one? |
cord-283485-xit6najq | This will strongly depend on: How strong will the acquired immunity after a first infection with SARS- CoV-2 be and how long will it last? |
cord-283485-xit6najq | To achieve herd immunity, how efficient will the vaccine need to be? |
cord-283485-xit6najq | What are the socioeconomic implications? ► |
cord-283485-xit6najq | What can we learn from them? |
cord-283485-xit6najq | What determines that an infection remains asymptomatic? ► |
cord-283485-xit6najq | What proportion of the population( critical population) will need to be vaccinated? |
cord-283485-xit6najq | What settings have been linked to SARS- CoV-2 transmission clusters? |
cord-283485-xit6najq | What type of vaccine will it be( live/ non- live, classic killed, DNA, or recombinant)? |
cord-283485-xit6najq | Which countries will get the vaccine first( implications for LICs/ LMICs)? |
cord-283485-xit6najq | Why do some COVID-19 patients infect many others, whereas most do n't spread the virus at all? |
cord-283485-xit6najq | Will it need special manufacture and transport conditions( such as cold chain)? |
cord-283485-xit6najq | Will there be any adverse effects? |
cord-283485-xit6najq | Will vaccination be acceptable in the population? |
cord-283485-xit6najq | Will vaccination be made mandatory, especially for international travel? |
cord-283485-xit6najq | a population- based cohort study Covid-19 and Italy's Case Fatality Rate: What's the Catch? |
cord-283485-xit6najq | how and why? |
cord-283485-xit6najq | to Vaccinate? |
cord-283485-xit6najq | ► How robust will be vaccine- acquired immunity? |